Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors

Colombo, R.

European Urology 50(2): 233-234

2006


ISSN/ISBN: 0302-2838
PMID: 18219715
Document Number: 597161

Document emailed within 1 workday
Secure & encrypted payments